Heidelberg Pharma AG Statistics

Total Valuation

Heidelberg Pharma AG has a market cap or net worth of GBP 97.75 million. The enterprise value is 66.95 million.

Market Cap	97.75M
Enterprise Value	66.95M

Important Dates

The next estimated earnings date is Monday, March 24, 2025.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.26%
Shares Change (QoQ)	-7.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	4.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.24
EV / Sales	9.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.63

Financial Position

The company has a current ratio of 6.01, with a Debt / Equity ratio of 0.00.

Current Ratio	6.01
Quick Ratio	4.55
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-91.95

Financial Efficiency

Return on equity (ROE) is -42.99% and return on invested capital (ROIC) is -29.23%.

Return on Equity (ROE)	-42.99%
Return on Assets (ROA)	-19.45%
Return on Capital (ROIC)	-29.23%
Revenue Per Employee	72,763
Profits Per Employee	-161,181
Employee Count	95
Asset Turnover	0.12
Inventory Turnover	0.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.41% in the last 52 weeks. The beta is -0.28, so Heidelberg Pharma AG's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	-24.41%
50-Day Moving Average	2.56
200-Day Moving Average	3.79
Relative Strength Index (RSI)	54.03
Average Volume (20 Days)	60

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Heidelberg Pharma AG had revenue of GBP 7.13 million and -15.80 million in losses. Loss per share was -0.34.

Revenue	7.13M
Gross Profit	5.73M
Operating Income	-18.35M
Pretax Income	-16.03M
Net Income	-15.80M
EBITDA	-17.76M
EBIT	-18.35M
Loss Per Share	-0.34

Full Income Statement

Balance Sheet

The company has 30.78 million in cash and 134,014 in debt, giving a net cash position of 30.65 million.

Cash & Cash Equivalents	30.78M
Total Debt	134,014
Net Cash	30.65M
Net Cash Per Share	n/a
Equity (Book Value)	30.15M
Book Value Per Share	0.67
Working Capital	36.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -25.19 million and capital expenditures -275,520, giving a free cash flow of -25.46 million.

Operating Cash Flow	-25.19M
Capital Expenditures	-275,520
Free Cash Flow	-25.46M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 80.41%, with operating and profit margins of -257.30% and -221.51%.

Gross Margin	80.41%
Operating Margin	-257.30%
Pretax Margin	-224.79%
Profit Margin	-221.51%
EBITDA Margin	-249.01%
EBIT Margin	-257.30%
FCF Margin	n/a

Dividends & Yields

Heidelberg Pharma AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.26%
Shareholder Yield	1.26%
Earnings Yield	-16.16%
FCF Yield	-26.05%

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

Heidelberg Pharma AG has an Altman Z-Score of -4.29. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.29
Piotroski F-Score	n/a